S'abonner

Gene-environment interaction in chronic disease: A European Science Foundation Forward Look - 25/11/11

Doi : 10.1016/j.jaci.2011.09.039 
Harald Renz, MD a, , Ingo B. Autenrieth, MD b, Per Brandtzæg, PhD c, William O. Cookson, MD, DPhil d, Stephen Holgate, DSc e, Erika von Mutius, MD f, Rudolf Valenta, MD g, Dirk Haller, PhD h,
a Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, Marburg, Germany 
b Institute of Medical Microbiology and Hygiene, University Hospital Tübingen, Tübingen, Germany 
c Laboratory for Immunochemistry and Immunopathology, Centre for Immune Regulations, University of Oslo, and the Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway 
d National Heart & Lung Institute, Imperial College London, London, United Kingdom 
e Department of Infection, Inflammation and Immunity, University of Southampton, and Southampton General Hospital, Southampton, United Kingdom 
f Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-Universität, Munich, Germany 
g Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria 
h ZIEL–Research Center for Nutrition and Food Science and CDD–Center for Diet and Disease, Technical University Munich, Freising-Weihenstephan, Germany 

Corresponding author: Harald Renz, MD, Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, Baldingerstraße, 35043 Marburg, Germany.

Abstract

Over the last half century, a dramatic increase in the incidence of chronic inflammatory diseases, such as asthma, allergy, and irritable bowel syndrome, has rightfully led to concern about how the modern lifestyle might inappropriately trigger innate physiologic defense mechanisms. Health care research in the Western world is faced with a significant challenge if it is to meet the needs of its populations in the decades ahead. The tools with which we hope to advance our understanding of the intrinsic and extrinsic mechanisms of chronic inflammatory diseases must therefore be adequately exploited and further developed to identify treatment and prevention strategies. There is an urgent need to prioritize resources and identify the most efficient scientific and societal initiatives to be adopted within this area. In this context national collaboration within Europe and beyond to establish state-of-the-art practices with an interdisciplinary perspective and promote an efficient exchange of best practices is essential. Such an approach likely represents the most efficient manner in which strategies for amelioration of the increase of chronic inflammatory diseases in the Western world can be achieved. The present report is based on a Forward Look initiative conducted by the European Medical Research Councils under the European Science Foundation. Experts from industry and academia, as well as relevant interest organizations, have been consulted in the process of conducting this initiative and have, based on this work, developed a set of final recommendations that target academic research, science funders, and policy makers.

Le texte complet de cet article est disponible en PDF.

Key words : Gene-environment, inflammation, immunology, chronic disease, Europe, lifestyle, genetic factors, interdisciplinary, policy, foresight

Abbreviations used : EMRC, ER, ESF, GWAS, IBD, MLN, NF-κB, NOD, SNP, SPF, T1D, T2D, TLR, Treg


Plan


 This Forward Look was financed by the European Science Foundation.
 Publication of this article was supported by the European Science Foundation.
 Disclosure of potential conflict of interest: E. von Mutius is a consultant for Novartis, GlaxoSmithKline, ALK-Abelló, and Protectimmun; has received speaker’s fees from InfectoPharm; has received research support from Airsonnett AB; is a member of the Expert Panel for the UK Research Excellence Framework; and is Associate Editor of the Journal of Allergy and Clinical Immunology. The rest of the authors declare that they have no relevant conflicts of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 128 - N° 6S

P. S27-S49 - décembre 2011 Retour au numéro
Article précédent Article précédent
  • Preface
  • Lars V. Kristiansen, Martin Röllinghoff, Stephane Berghmans, Liselotte Højgaard

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.